Jan 18 (Reuters) - Panacea Biotec Ltd
* Panacea Biotec Ltd says ANDA approval for us market and lta & award from un agencies for supply of pentavalent vaccine (easyfive-TT)
* Panacea Biotec Ltd says plans to launch product within Q1 2017 via distribution partner in US
* Panacea Biotec Ltd says drug used for treatement of migraine in adults and pediatric patients Source text - (bit.ly/2jISFEc) Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.